Abstract
The pathophysiological process following traumatic brain injury is extremely complex and not fully understood. Recent developments have further advanced our knowledge of the cellular and molecular mechanisms that cause this damage. The excitotoxic damage, alterations in calcium homeostasis and free radical induced damage are thought to be the key pathways in this process. It is believed that the final target of all these pathways is the mitochondria, through the alteration in the mitochondrial permeability transition pore. Moreover, the inflammatory response may be important in the exacerbation of secondary damage but its exact role is not very well known. Further advances in our understanding of the cellular and molecular mechanisms will be crucial in the design of new therapies that should improve the prognosis of the traumatic brain injury patients.
Keywords: head injury, hypoxia, brain, excitatory amino acids, oxidative stress, calcium homeostasis, mitochondria dysfunction
Current Pharmaceutical Design
Title: Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
Volume: 10 Issue: 18
Author(s): Enriquez P and Bullock R.
Affiliation:
Keywords: head injury, hypoxia, brain, excitatory amino acids, oxidative stress, calcium homeostasis, mitochondria dysfunction
Abstract: The pathophysiological process following traumatic brain injury is extremely complex and not fully understood. Recent developments have further advanced our knowledge of the cellular and molecular mechanisms that cause this damage. The excitotoxic damage, alterations in calcium homeostasis and free radical induced damage are thought to be the key pathways in this process. It is believed that the final target of all these pathways is the mitochondria, through the alteration in the mitochondrial permeability transition pore. Moreover, the inflammatory response may be important in the exacerbation of secondary damage but its exact role is not very well known. Further advances in our understanding of the cellular and molecular mechanisms will be crucial in the design of new therapies that should improve the prognosis of the traumatic brain injury patients.
Export Options
About this article
Cite this article as:
P Enriquez and R. Bullock, Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury, Current Pharmaceutical Design 2004; 10 (18) . https://dx.doi.org/10.2174/1381612043384060
DOI https://dx.doi.org/10.2174/1381612043384060 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Alzheimer’s Disease Genetic Risk Factor APOE-ε4 Also Affects Normal Brain Function
Current Alzheimer Research Symmetry Plane Detection in Brain Image Analysis: A Survey
Current Medical Imaging Progress in the Rational Design for Polypharmacology Drug
Current Pharmaceutical Design Renal Artery Stenosis: Current Perspectives on Imaging and Endovascular Management
Current Hypertension Reviews Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Age Matching Animal Models to Humans - Theoretical Considerations
Current Drug Discovery Technologies Glucose Transporters Regulation on Ischemic Brain: Possible Role as Therapeutic Target
Central Nervous System Agents in Medicinal Chemistry Cerebral Microemboli Increase β-amyloid Protein Deposition, MMP-9, and GFAP Expression in the Alzheimer`s Model of APP/PS1 Double Transgenic Mice
Current Neurovascular Research VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets Efficacy and Safety Profile of Aliskiren: Practical Implications for Clinicians
Current Drug Safety Pediatric Catatonia: Updating An Old Syndrome in Young People
Current Psychiatry Reviews Why and How We Should Treat Elderly Patients with Hypertension?
Current Vascular Pharmacology Medical Image Processing Technology for Diagnosing and Treating Cancers
Recent Patents on Biomedical Engineering (Discontinued) Hydrogen Sulfide: From Physiology to Pharmacology
Inflammation & Allergy - Drug Targets (Discontinued) Identification and Temporal Characterization of Features Associated with the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease
Current Alzheimer Research Radiological Diagnosis of Renal Thrombosis in Children
Current Pediatric Reviews Phytotherapeutic and Natural Compound Applications for Age-Related, Inflammatory and Serious Eye Ailments
Current Molecular Pharmacology Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Systems Biology: A Powerful Tool for Drug Development
Current Topics in Medicinal Chemistry Role of Microfluidics in Blood-Brain Barrier Permeability Cell Culture Modeling: Relevance to CNS Disorders
CNS & Neurological Disorders - Drug Targets